Scientists around the world are hard at work figuring out how to combat the many forces threatening the global food supply.

What may sound like a spa day for frogs is all part of a global effort to fight the chytrid fungus — the deadly pathogen responsible for what scientists have called the largest disease-driven loss of ...

February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

Beam Therapeutics BEAM shares are rising Tuesday after the company reported quarterly results. Beam Therapeutics stock is surging to new heights today. What’s fueling BEAM momentum? Beam Surpasses ...

Oily skin has always been one of my biggest insecurities, which is probably why I’ve made it my mission, and my literal job, ...

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...

Will a world where cancer is treated with a single injection arrive? The so-called ‘in vivo CAR-T’ method, which directly alters immune cells within the body, is recently transforming the cancer ...

In a world where agriculture is confronted with unprecedented challenges—such as climate variability, emerging pathogens, and ...

The FDA released a much-anticipated draft guidance on how makers of rare disease genetic medicines can leverage a platform ...

New Early Access Express License provides streamlined, affordable access to foundational CRISPR/Cas9 intellectual property to ...

"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...